order
evalu
infecti
agent
associ
first
episod
sever
acut
wheez
otherwis
healthi
infant
defin
role
recurr
patient
itali
age
month
hospit
first
acut
episod
wheez
prospect
enrol
octob
march
upon
enrol
nasopharyng
swab
collect
realtim
pcr
detect
respiratori
syncyti
viru
rsv
type
b
influenza
viru
type
b
adenoviru
parainfluenza
virus
type
rhinoviru
human
metapneumoviru
human
coronaviru
type
bocaviru
enteroviru
paraechoviru
nasopharyng
aspir
also
obtain
detect
atyp
bacteria
least
one
infecti
agent
identifi
children
rsv
frequent
detect
pathogen
preval
significantli
higher
pathogen
age
group
significantli
higher
children
age
month
age
month
children
rsv
infect
experienc
recurr
wheez
viral
load
significantli
higher
children
without
recurr
wheez
studi
show
rsv
main
reason
hospit
first
wheez
episod
infant
appear
pathogen
associ
high
frequenc
recurr
high
viral
load
seem
strictli
relat
likelihood
recurr
clin
microbiol
infect
wheez
episod
common
reason
hospit
infant
young
children
caus
signific
clinic
socioeconom
problem
respiratori
syncyti
viru
rsv
long
consid
main
pathogen
associ
wheez
demonstr
lower
airway
ill
caus
rsv
earli
childhood
independ
riskfactor
develop
subsequ
wheez
episod
adolesc
howev
recent
introduc
simpl
sensit
diagnost
techniqu
capabl
identifi
infecti
agent
respiratori
secret
shown
number
pathogen
detect
children
wheez
frequent
found
virus
rhinovirus
influenza
virus
human
metapneumoviru
hmpv
human
coronavirus
hcov
human
bocaviru
atyp
bacteria
mycoplasma
pneumonia
chlamydophila
pneumonia
import
infecti
agent
caus
wheez
yet
precis
defin
studi
carri
far
consid
pathogen
togeth
frequent
led
opposit
conclus
particular
still
clear
pathogen
realli
respons
sever
wheez
requir
hospit
import
predispos
children
subsequ
develop
recurr
wheez
asthma
defin
role
pathogen
precis
seem
particularli
import
case
children
age
year
acut
wheez
earli
life
often
requir
hospit
risk
earli
infect
associ
greater
risk
episod
seem
demonstr
experiment
model
also
suggest
human
studi
aim
studi
evalu
infecti
agent
associ
first
episod
acut
wheez
requir
hospit
otherwis
healthi
infant
first
year
life
defin
role
caus
recurr
prospect
studi
carri
octob
march
institut
paediatr
univers
milan
itali
three
associ
hospit
legnano
pavia
imola
studi
protocol
approv
institut
review
board
four
hospit
written
inform
consent
parent
legal
guardian
obtain
infant
enrol
studi
involv
otherwis
healthi
infant
age
less
month
hospit
one
particip
hospit
first
acut
episod
wheez
studi
period
exclus
criteria
prematur
birth
presenc
chronic
diseas
increas
risk
complic
respiratori
infect
includ
chronic
disord
pulmonari
cardiovascular
system
chronic
metabol
diseas
neoplasia
kidney
liver
dysfunct
haemoglobinopathi
immunosuppress
genet
neurolog
disord
refus
particip
upon
admiss
demograph
characterist
medic
histori
children
systemat
record
use
standard
written
questionnair
complet
physic
examin
children
diagnosi
infecti
wheez
base
wellestablish
criteria
enrol
sever
wheez
defin
basi
global
evalu
sign
symptom
particular
wheez
consid
sever
presenc
tachypnoea
breath
min
tachycardia
beat
min
nasal
flare
retract
prolong
expiratori
phase
puls
oximetri
dehydr
reduct
bodi
weight
patient
underw
chest
radiographi
pneumonia
defin
basi
presenc
reticulonodular
infiltr
segment
lobar
consolid
bilater
consolid
upon
enrol
virocult
medic
wire
equip
corsham
uk
nasopharyng
swab
use
collect
specimen
detect
virus
nasopharyng
aspir
obtain
detect
atyp
bacteria
acut
serum
sampl
also
obtain
order
assay
antibodi
pneumonia
c
pneumonia
hospit
stay
children
clinic
sign
symptom
monitor
daili
treat
oxygen
satur
receiv
bronchodil
steroid
antibiot
intraven
fluid
chest
physiotherapi
judg
necessari
attend
paediatrician
discharg
abl
maintain
oximetri
without
oxygen
parent
ask
bring
immedi
studi
centr
recurr
worsen
sign
symptom
medic
histori
gener
physic
condit
clinic
symptom
patient
reevalu
investig
blind
aetiolog
find
week
month
enrol
children
histori
wheez
respiratori
tract
infect
care
assess
first
visit
second
serum
sampl
obtain
order
assay
pneumonia
c
pneumonia
titr
convalesc
phase
virocult
nasopharyng
swab
test
mean
previous
describ
realtim
pcr
rsv
type
b
influenza
viru
type
b
adenoviru
parainfluenza
viru
type
rhinoviru
hmpv
hcov
type
genotyp
bocaviru
enteroviru
paraechoviru
depart
virolog
erasmu
medic
centr
rotterdam
netherland
total
nucleic
acid
routin
isol
magnapurelc
isol
station
roch
appli
scienc
penzberg
germani
univers
intern
control
viru
use
monitor
whole
process
nucleic
acid
isol
realtim
detect
inhous
realtim
pcr
test
virus
intern
control
phocin
distemp
viru
design
use
primer
express
softwar
appli
biosystem
nieuwerkerk
ijssel
netherland
rna
amplifi
singletub
twostep
reaction
use
taqman
revers
transcriptas
reagent
kit
pcr
core
reagent
kit
appli
biosystem
abi
abi
sequenc
detect
system
appli
biosystem
posit
control
assay
cultur
control
viru
use
except
case
genotyp
construct
synthes
basi
publish
sequenc
contain
part
nucleoprotein
gene
clone
basi
profici
test
data
sensit
assay
estim
less
copi
ml
nasopharyng
aspir
evalu
presenc
pneumonia
dna
c
pneumonia
dna
use
valid
nest
pcr
pathogen
previous
describ
assay
includ
posit
neg
control
primer
set
use
pneumoniaespecif
amplif
follow
primer
pneumonia
nest
pcr
touchdown
nest
pcr
detect
c
pneumonia
dna
perform
use
primer
design
detect
major
protein
outermembran
serum
sampl
test
igm
igg
antibodi
pneumonia
elisa
pantec
itali
igm
igg
antibodi
c
pneumonia
microimmunofluoresc
labsystem
finland
previous
describ
acut
pneumonia
c
pneumonia
infect
diagnos
child
show
signific
antibodi
respons
one
pathogen
pair
sera
pneumonia
igmspecif
titer
fourfold
increas
igg
antibodi
c
pneumonia
igmspecif
titer
fourfold
increas
igg
antibodi
nasopharyng
aspir
pcrposit
accord
previous
establish
criteria
data
analyz
use
sa
window
sa
institut
cari
nc
usa
p
valu
consid
statist
signific
comparison
made
infant
age
month
age
month
parametr
data
evalu
mean
analysi
varianc
anova
abnorm
distribut
nonparametr
data
analyz
use
kruskalw
test
categor
data
analyz
mean
conting
analysi
chisquar
fisher
test
studi
enrol
infant
age
less
month
hospit
first
acut
episod
wheez
male
mean
age
standard
deviat
month
fiftythre
patient
age
less
month
age
month
fullterm
newborn
born
mean
eutoc
deliveri
physiolog
neonat
histori
twentytwo
famili
histori
asthma
live
urban
area
none
attend
daycar
centr
enrol
differ
demograph
characterist
two
age
group
tabl
show
infecti
agent
detect
studi
popul
least
one
agent
identifi
children
sixtyon
patient
infect
singl
pathogen
coinfect
differ
virus
p
vs
patient
infect
singl
pathogen
pathogen
detect
nine
case
p
vs
patient
infect
singl
pathogen
signific
differ
preval
singl
infect
coinfect
absenc
pathogen
two
age
group
rsv
frequent
detect
pathogen
preval
significantli
higher
pathogen
age
group
significantli
higher
children
age
month
age
month
except
children
rsv
coinfect
virus
found
youngest
age
group
wherea
pneumonia
found
child
among
patient
infect
singl
pathogen
rsv
case
due
rsv
infant
rsv
b
influenza
case
due
influenza
viru
two
infant
influenza
b
viru
one
hcov
case
due
hcov
two
infant
hcov
genotyp
one
singl
infect
due
adenoviru
rhinoviru
parainfluenza
virus
type
hcov
hcov
enteroviru
paraechoviru
observ
virus
detect
infant
coinfect
c
pneumonia
never
detect
tabl
show
clinic
present
outcom
respect
infant
infect
singl
pathogen
onset
first
wheez
episod
gradual
children
present
fever
hospit
sever
symptom
chest
examin
show
prolong
expiratori
phase
wheez
chest
radiograph
show
sign
pneumonia
acut
episod
wheez
patient
treat
bronchodil
mani
receiv
antibiot
minor
receiv
steroid
rsv
hcov
case
requir
intraven
fluid
supplement
oxygen
administ
chest
physiotherapi
requir
atelectasi
small
number
patient
rsv
infect
durat
hospit
vari
day
signific
differ
clinic
present
drug
administr
durat
hospit
patient
respect
pathogen
two
age
group
howev
initi
episod
wheez
led
enrol
infant
rsv
infect
experienc
least
one
episod
follow
month
tabl
summar
relationship
rsv
clinic
data
clinic
present
outcom
similar
regardless
type
rsv
howev
although
viral
load
correl
sever
diseas
number
rsv
copi
ml
significantli
higher
children
recurr
wheez
without
rsv
respiratori
syncyti
viru
hcov
human
coronavirus
hmpv
human
metapneumoviru
signific
differ
pathogen
age
group
tabl
outcom
infant
infect
singl
pathogen
rsv
respiratori
syncyti
viru
hcov
human
coronavirus
hmpv
human
metapneumoviru
signific
differ
pathogen
age
group
find
indic
rsv
main
pathogen
associ
first
episod
wheez
requir
hospit
infant
younger
year
respiratori
pathogen
recent
suggest
play
signific
pathogen
role
margin
import
stage
infant
studi
sampl
infect
rsv
wherea
preval
pathogen
never
exceed
absolut
relev
rsv
particularli
evid
among
infant
age
month
infect
singl
pathogen
rsv
infect
howev
even
first
month
life
associ
wheez
respiratori
infect
due
pathogen
rsv
uncommon
occur
eight
children
singl
pathogen
detect
import
rsv
infant
first
wheez
episod
also
clear
coinfect
case
case
one
pathogen
detect
rsv
infect
studi
carri
late
autumn
winter
period
rsv
influenza
virus
often
associ
epidem
attack
may
limit
found
respiratori
pathogen
includ
recent
identifi
virus
atyp
bacteria
isol
children
throughout
year
therefor
possibl
studi
extend
longer
period
proport
wheez
episod
associ
differ
infecti
pathogen
may
slightli
differ
howev
case
wheez
first
year
life
occur
late
autumn
winter
unlik
differ
would
significantli
chang
outcom
current
studi
knowledg
real
import
differ
respiratori
pathogen
caus
wheez
first
year
life
rel
poor
publish
studi
infecti
wheez
children
consid
singl
pathogen
consid
subject
age
less
year
separ
group
addit
paper
specifi
whether
studi
wheez
episod
first
case
diseas
child
admit
precis
defin
howev
result
studi
compar
differ
infecti
agent
atyp
bacteria
associ
wheez
earli
life
also
highlight
primari
role
rsv
clinic
relev
wheez
episod
seem
depend
associ
infecti
agent
although
small
number
children
current
studi
infect
due
pathogen
rsv
data
regard
onset
sever
diseas
drug
administr
durat
hospit
similar
regardless
aetiolog
find
suggest
respiratori
pathogen
caus
wheez
lead
similar
clinic
present
hospit
infant
howev
mean
clinic
impact
studi
pathogen
similar
possibl
respiratori
pathogen
rsv
may
caus
frequent
although
less
sever
wheez
children
requir
hospit
recurr
observ
patient
infect
rsv
find
rsv
remain
import
pathogen
associ
first
episod
wheez
first
year
life
subject
infect
viru
risk
develop
longterm
airway
hyperrespons
confirm
data
suggest
rsv
induc
agerel
chang
lung
function
mous
studi
shown
probabl
chronic
alter
lung
function
greater
earlier
first
rsv
infect
occur
probabl
subsequ
infect
follow
sever
wheez
earlier
infect
seem
induc
polar
respons
case
reinfect
caus
exacerb
diseas
indic
enhanc
pulmonari
resist
mucu
hyperproduct
eosinophilia
high
cytokin
level
data
suggest
human
period
rsv
infect
lead
greater
risk
wheez
episod
extend
least
end
first
year
life
proport
children
current
studi
infect
rsv
experienc
new
episod
wheez
month
follow
first
episod
virtual
age
group
wherea
none
children
whose
first
wheez
episod
associ
infecti
agent
rsv
experienc
episod
studi
also
demonstr
first
time
rsv
viral
load
predict
tendenc
recur
diseas
sever
children
hospit
first
wheez
episod
contrari
type
rsv
seem
relat
clinic
present
outcom
recurr
recent
studi
assess
role
host
viral
factor
influenc
rsv
ill
result
controversi
relationship
rsv
genotyp
clinic
data
complet
establish
rsv
viral
load
appear
correl
diseas
sever
studi
other
studi
compar
rsv
viral
load
outpati
hospit
infant
wheez
well
paediatr
patient
differ
type
respiratori
tract
infect
requir
clarifi
role
acut
ill
howev
first
studi
correl
rsv
viral
load
develop
subsequ
recurr
wheez
primari
concern
rsv
infect
acquir
earli
life
conclus
find
show
rsv
main
caus
hospit
first
wheez
episod
first
year
life
pathogen
associ
high
frequenc
recurr
high
rsv
viral
load
appear
strictli
relat
recurr
result
suggest
everi
effort
made
prevent
rsv
infect
contain
rsv
replic
first
year
life
reduc
risk
subsequ
episod
wheez
studi
support
part
grant
italian
ministri
univers
project
appropri
inform
consent
obtain
studi
conduct
accord
guidelin
human
experiment
specifi
author
institut
none
author
commerci
associ
might
pose
conflict
interest
